The Ohio Bioscience Report
The Ohio Bioscience Report is published by BioOhio, the state’s bioscience organization, to inform the public on the progress of Ohio’s bioscience industry, research endeavors, and the community at large.
The following are key findings, with a downloadable 2-page summary, from the upcoming Ohio Bioscience Report.
The report presents factual findings analyzing the bioscience sector within the state and its six geographic regions. To present content relevant to the full continuum of bioscience in Ohio, information is provided on the six core bioscience subsectors as well as critical contributors to the industry. All of these sectors have a common goal, to improve the quality of life for our community. Click here to learn more about these fields.
- Agricultural Biotechnology
- Medical & Testing Labs
- Medical Devices & Equipment
- Medical Product Distribution
- Pharmaceuticals & Therapeutics
- Research & Development
- Bioscience Education Institutions
- Contract Manufacturers & Suppliers
- Health and Medical Insurance Carriers
- Health IT Companies
- Healthcare Providers
- Professional Service Providers
Ohio’s bioscience industry continues its strong history of innovation and discovery, with over 4,000 organizations manufacturing & distributing products, providing essential services, or researching the next breakthrough at more than 4,800 facilities around the state.
The bioscience industry’s economic impact is felt throughout the state, with bioscience-related companies found in 83 of 88 Ohio counties. All six Ohio regions have experienced growth in the bioscience industry and play a role in advancing critical discoveries.
Bioscience firms employ over 81,000 people in Ohio at companies ranging from the large and well known such as Abbott, Athersys, Battelle, Cardinal Health, Johnson & Johnson, and Midmark, to young and growing companies including Abeona Therapeutics, Clarametyx Biosciences, and Enable Injections.
Bioscience companies continue to expand operations and announce new facilities in the state, with 40 projects announced in 2019, projecting the creation of 4,474 jobs and over $757 million in capital investment. AmerisourceBergen, AtriCure, Camargo Pharmaceutical Services, Charles River Laboratories, Formlabs Ohio, Hitachi Healthcare Americas, McKesson, Stirling Ultracold, and Tosoh USA are all among the many companies growing in Ohio.
of 88 Ohio Counties
Private Investment (2019)
Private Investment (2020 Preliminary 6/20)
Ohio bioscience companies attracted over $2 billion in funding in 2019, from sources including venture capital, exits, angel investment, federal research grants, and state initiatives.
BioOhio analysis indicates that over 100 Ohio bioscience-related companies announced $490 million in private investment in 2019, one of the highest levels recorded since BioOhio began tracking deals in 2004. Exit activity in the state remained strong in 2019, totaling over $570 million.
Bioscience education continues to thrive in Ohio. In 2018, 11,997 bioscience-related degrees and certificates were awarded to students in Ohio, an increase of 77% since 2006. The number of schools with bioscience-related programs has also increased, from 79 in 2006 to over 90 public and private schools furthering the capabilities of Ohio’s talented workforce in 2018.